-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BcYTbWS3eMjd2jBbKyMbqBMIDiiBP47/Sscofy7ofVtVk85I2kCMWF6h8W3bbYpy GkbNvascHp9M8xUI1So3Pw== 0000943663-05-000281.txt : 20050503 0000943663-05-000281.hdr.sgml : 20050503 20050503144021 ACCESSION NUMBER: 0000943663-05-000281 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050503 DATE AS OF CHANGE: 20050503 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VIROPHARMA INC CENTRAL INDEX KEY: 0000946840 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232789550 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48239 FILM NUMBER: 05794477 BUSINESS ADDRESS: STREET 1: 397 EAGLEVIEW BLVD CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6104587300 MAIL ADDRESS: STREET 1: 397 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ATTICUS CAPITAL LLC CENTRAL INDEX KEY: 0001054828 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 45TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2128298106 MAIL ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 45TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATTICUS CAPITAL INC DATE OF NAME CHANGE: 19980518 SC 13G/A 1 viropharma13g-2.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 2)

VIROPHARMA, INC.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

928241108
(CUSIP Number)

April 21, 2005
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

/_/ Rule 13d-1(b)
/X/ Rule 13d-1(c)
/_/ Rule 13d-1(d)

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1	NAME OF REPORTING PERSON SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Atticus Capital, L.L.C.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) /_/ (b) /_/
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			5	SOLE VOTING POWER 1,357.905
			6	SHARED VOTING POWER 0
			7	SOLE DISPOSITIVE POWER 1,357,905
			8	SHARED DISPOSITIVE POWER 0
9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,357,905
10		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES /_/
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.87%
12		TYPE OF REPORTING PERSON OO

1	NAME OF REPORTING PERSON SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Timothy R. Barakett N/A
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) /_/ (b) /_/
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Canada
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			5	SOLE VOTING POWER 0
			6	SHARED VOTING POWER 1,357,905
			7	SOLE DISPOSITIVE POWER 0
			8	SHARED DISPOSITIVE POWER 1,357,905
9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,357,905
10		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES /_/
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.87%
12		TYPE OF REPORTING PERSON IN

Item 1	(a).	Name of Issuer: Viropharma, Inc.

	(b).	Address of Issuer's Principal Executive Offices:

		397 Eagleview Boulevard
		Exton, PA 19341

Item 2	(a).	Name of Persons Filing:

		(i) Atticus Capital, L.L.C. ("Atticus")
		(ii) Timothy R. Barakett ("Barakett")

	(b).	Address of Principal Business Office for Each of the Above:

		152 West 57^th Street, 45^th Floor
		New York, NY 10019

	(c).	Citizenship or Place of Organization:

		(i) Atticus: Delaware
		(ii) Barakett: Canada

	(d).	Title of Class of Securities: Common Stock

	(e).	CUSIP Number: 929241108

Item 3.	If this Statement is Filed Pursuant to Rules 13d-1(b) or 13d-2(b) or (c), Check Whether the Person Filing is a:

	(a)	[ ] Broker or dealer registered under Section 15 of the Exchange Act;
	(b)	[ ] Bank as defined in Section 3(a)(6) of the Exchange Act;

	(c)	[ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act;

	(d)	[ ] Investment company registered under Section 8 of the Investment Company Act;

	(e)	[ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

	(f)	[ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

	(g)	[ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

	(h)	[ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act;

	(i)	[ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940;

	(j)	[ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

Item 4.	Ownership.

	(a).	Amount beneficially owned:

		(i) Atticus:	1,357,905
		(ii) Barakett:	1,357,905

	(b).	Percent of class:

		(i) Atticus:	4.87%
		(ii) Barakett:	4.87%

	(c).	Number of shares as to which such person has:


(1) Sole power to vote or to direct the vote:

	(i) Atticus:	1,357,905
	(ii) Barakett:	0

(2) Shared power to vote or to direct the vote:

	(i) Atticus:	0
	(ii) Barakett:	1,357,905

(3) Sole power to dispose or to direct the disposition of :

	(i) Atticus:	1,357,905
	(ii) Barakett:	0

(4) Shared power to dispose or to direct the disposition of:

	(i) Atticus:	0
	(ii) Barakett:	1,357,905

Item 5. Ownership of Five Percent or Less of a Class: [X]

The Reporting Persons have ceased to be the beneficial owners of more than five percent of the Issuer's outstanding class of Common Stock.

Item 6. Ownership of More Than Five Percent on Behalf of Another Person:

Not Applicable

Item 7. Identification and Classification of Subsidiaries which Acquired the Security Being Reported on by the Parent Holding Company:

Not Applicable

Item 8. Identification and Classification of Members of the Group:

Not Applicable

Item 9. Notice of Dissolution of Group:

Not Applicable

Item 10. Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purposed of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Disclaimer

In accordance with Rule 13d-4 of the Securities Exchange Act of 1934, each of the persons filing this statement expressly disclaim the beneficial ownership of the securities covered by this statement and the filing of this report shall not be construed as an admission by such persons that they are the beneficial owners of such securities.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

		ATTICUS CAPITAL, L.L.C.


Date: May 3, 2005		By: /s/ Timothy R. Barakett*
		Timothy R. Barakett
		Managing Member


		TIMOTHY R. BARAKETT


Date: May 3, 2005		By: /s/ Timothy R. Barakett*
		Timothy R. Barakett

* by Nandita Hogan as Attorney-In-Fact

EXHIBIT 1

JOINT FILING AGREEMENT AMONG ATTICUS CAPITAL, L.L.C. AND TIMOTHY R. BARAKETT

WHEREAS, in accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934 (the "Act"), only one joint statement and any amendments thereto need to be filed whenever one or more persons are required to file such a statement or any amendments thereto pursuant to Section 13(d) of the Act with respect to the same securities, provided that said persons agree in writing that such statement or amendments thereto is filed on behalf of each of them;

NOW, THEREFORE, the parties hereto agree as follows:

ATTICUS CAPITAL, L.L.C. AND TIMOTHY R. BARAKETT hereby agree, in accordance with Rule 13d-1(k) under the Act, to file a statement on Schedule 13G relating to their ownership of the Common Stock of the Issuer and do hereby further agree that said statement shall be filed on behalf of each of them.

		ATTICUS CAPITAL, L.L.C.


Date: May 3, 2005		By: /s/ Timothy R. Barakett*
		Timothy R. Barakett
		Managing Member


		TIMOTHY R. BARAKETT


Date: May 3, 2005		By: /s/ Timothy R. Barakett*
		Timothy R. Barakett

* by Nandita Hogan as Attorney-In-Fact

EXHIBIT 2

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that I, TIMOTHY R. BARAKETT, hereby make, constitute and appoint each of JOHN F. BROWN and NANDITA HOGAN, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as chief executive officer of, member of or in other capacities with Atticus Capital, L.L.C. ("Atticus") and each of its affiliates or entities advised by me or Atticus, all documents, certificates, instruments, statements, filings and agreements ("documents") to be filed with or delivered to any foreign or domestic governmental or regulatory body or required or requested by any other person or entity pursuant to any legal or regulatory requirement relating to the acquisition, ownership, management or disposition of securities, futures contracts or other investments, and any other documents relating or ancillary thereto, including without limitation all documents relating to filings with the Commodities Futures Trading Commission and National Futures Association, the United States Securities and Exchange Commission (the "SEC") pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934 (the "Act") and the rules and regulations promulgated thereunder, including all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Act and any information statements on Form 13F required to be filed with the SEC pursuant to Section 13(f) of the Act. All past acts of the attorneys-in-fact in furtherance of the foregoing are hereby ratified and confirmed.

THIS POWER OF ATTORNEY shall remain in full force and effect until either revoked in writing by the undersigned or until such time as the person or persons to whom power of attorney has been hereby granted cease(s) to be an employee of Atticus Capital, L.L.C. or one of its affiliates.

IN WITNESS WHEREOF, the undersigned has duly subscribed these presents as of April 26, 2005.


		/s/ Timothy R. Barakett
		Timothy R. Barakett

-----END PRIVACY-ENHANCED MESSAGE-----